Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Zachary Litvack

Neurological Surgery Seattle, WA Medical Doctor

NPI 1235347980 CMS profile 56415

1600 E Jefferson St, Suite 101, Seattle, WA 98122

Open in the dashboard

General payments

$13,772

49 records reported · program years 2019–2025

Research payments

$24,075

Paid to them · 3 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$14,972 paid to institutions, not to them · program years 2019–2022

Through program year 2025, Zachary Litvack of Seattle, WA is reported in the CMS Open Payments database as having received $13,772 across 49 general payments and $24,075 in research payments paid to them. Separately, studies naming them as principal investigator received $14,972 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 84th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $11,628 24
2024 Research $7,875 1
2023 General $516 8
2023 Research $5,400 1
2022 General $134 1
2022 Research $10,800 1
2020 General $289 2
2019 General $1,205 14

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Zachary Litvack
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Zachary Litvack were reported at $11,628. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Zachary Litvack Neurological Surgery median Middle half National median
2019 $1,205 $582 $138–$3,006 $163
2020 $289 $294 $76–$2,174 $114
2021 $0 $387 $105–$2,432 $132
2022 $134 $542 $139–$2,989 $149
2023 $516 $534 $145–$2,697 $160
2024 $0 $574 $155–$3,046 $164
2025 $11,628 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $10,483 19 payments
  2. Monteris Medical Corporation $1,000 7 payments
  3. Integra LifeSciences Corporation $634 5 payments
  4. NICO Corporation $319 2 payments
  5. Arrinex, Inc. $252 2 payments
  6. Medtronic USA, Inc. $223 4 payments
  7. Stryker Corporation $188 2 payments
  8. Globus Medical, Inc. $156 3 payments
  9. MicroVention, Inc. $141 1 payment
  10. Boston Scientific Corporation $121 1 payment
  11. Other $255 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $8,140 1 payment
  2. Food and Beverage $2,874 33 payments
  3. Travel and Lodging $2,757 15 payments
Products named General payments · program years 2019–2025
  1. STEALTHSTATION S8 PLATFORM $10,243 16 payments
  2. Neuroblate $1,000 7 payments
  3. CUSA CLARITY Neuro Critical Care $342 3 payments
  4. DURAGEN $342 3 payments
  5. DURASEAL EXACT $342 3 payments
  6. CODMAN HAKIM PRECISION VALVE $342 3 payments
  7. CODMAN CERTAS Neuro Critical Care $342 3 payments
  8. CODMAN CERTAS Neuro Critical Care $293 2 payments
  9. CUSA CLARITY Neuro Critical Care $293 2 payments
  10. CODMAN HAKIM $293 2 payments
  11. Other $3,987 35 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. NX Development Corp. $24,075 3 payments

Billing to Medicare

Part B · data year 2024 · 33 billing codes

Paid by Medicare

$65,352

Medicare's payments for the services billed

Medicare patients

150

Average age 72

Services billed

287

94 women, 56 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 64%
Arthritis 51%
Depression 27%
Diabetes 17%
Osteoporosis 17%
Cancer 16%
Chronic kidney disease 15%
Atrial fibrillation 14%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

52 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in Washington

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record